PREVALENCE OF HEPATITIS B VIRUS INFECTION AMONG HIV PATIENTS INBENUE SOUTH SENATORIAL DISTRICT, NIGERIA
DOI :
https://doi.org/10.62050/fjst2024.v8n2.319Mots-clés :
Hepatitis B virus, Human immunodeficiency virus, Co-infection, Seroprevalence, Benue StateRésumé
Hepatitis B infection seriously threatens global public health, especially in developing nations. Despite several
efforts on ascertaining the true prevalence of HBV, it tenaciously varies across different locations and subpopulations, particularly among those at risk of infection such as the HIV-infected population. This study aimed at
determining the sero-prevalence of HIV-HBV co-infection in Benue South Senatorial District, Nigeria. This crosssectional study was conducted in four anti-retroviral therapy (ART) specialized clinics between May 1, and
September 2023 using pretested questionnaires, after obtained ethical approval and informed consent.Blood
samples of participants were screened using HBsAg testing kitsand the results were interpreted according to the
manufacturer’s instructions. The screening for HIV-HBV co-infection showed a sero-prevalence of 25/457 (5.47%).
The distribution based on clinic location was 12(48%) GH Otukpo, 8(32%) GH Oju, 2(8%) GH Ugbokpo and
3(12%) SMH Okpoga. The distribution also revealed that most cases were in the age group 40-49 and the female
gender.The prevalence showed that only 3/25 (12.0%) reported a history of sexually transmitted diseases other than
HIV while 2/25 (8.0%) had a history of multiple sex partners. Most co-infected cases 23/25(92.0%) had no history
of same-sex relationships and 23/25(92.0%) had recent history of unprotected sex. In Nigeria, hepatitis B infection
remains a significant public health problem. Notable preventive strategies include abstinence from sex, avoidance
of multiple sex partners, strict adherence to safe sex, and avoiding contact with infected body fluids. Other
strategies such as averting mother-to-infant hepatitis B transmission, scale-up of screening programs and extensive
vaccination programs are eminently recommended in the course of HBV control.
##plugins.themes.default.displayStats.downloads##
Références
Anejo-Okopi, J., Aju-Ameh, O. C., Agboola, O., Edegbene, O. A., Ujoh, A. J., Audu, O., et al. (2023). Prevalence of Hepatitis B virus infection and effects of service charges on notification among pregnant women attending antenatal care at General Hospital, Otukpo, Nigeria. Annals of Medical Research and Practice, 4(1), 1–6. https://doi.org/10.25259/anmrp_14_2022
Angell, B., Sanuade, O., Adetifa, I. M. O., Okeke, I. N., Adamu, A. L., Aliyu, M. H., et al. (2022). Population health outcomes in Nigeria compared with other West African countries, 1998–2019: a systematic analysis for the Global Burden of Disease Study. Lancet, 399, 1117–1129. https://doi.org/10.1016/S0140-6736(21)02722-7
Awili, H., Gitao, G. and Muchemi, G. (2020). Seroprevalence and risk factors for Hepatitis B Virus infection in adolescent blood donors within selected counties of Western Kenya. Biomed Research International, 2020, 1–6. https://doi.org/10.1155/2020/8578172
Coffin, C. S., Osiowy, C., Myers, R. P. and Gill, M. J (2013). Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients. Journal of Clinical Virology, 57(2), 103–108. https://doi.org/10.1016/j.jcv.2013.02.004
Cookey, T. I., Okonko, I. O. and Frank-Peterside, N. (2021). HIV and HBV coinfections in the highly HIV-infected population of Rivers State, Nigeria. Asian Journal of Advanced Research and Reports, 15(6), 1–10. http://dx.doi.org/10.9734/ajarr/2021/v15i630402
Haeuser, E., Serfes, A. L., Cork, M. A., Yang, M., Abbastabar, H., Abhilash, E. S. et al. (2022). Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018. BMC Medicine, 20, 488. https://doi.org/10.1186/s12916-022-02639-z
Khalifa, A., Stover, J., Mahy, M., Idele, P., Porth, T. and Lwamba, C. (2019). Demographic change and HIV epidemic projections to 2050 for adolescents and young people aged 15-24. Global Health Action, 12(1), 1662685. https://doi.org/10.1080/16549716.2019.1662685
Malu, A. O., Achinge, G. I., Utoo, P. M., Kur, J. T. and Obekpa, S. A. (2020). Prevalence of Hepatitis B surface antigen and antibodies to Hepatitis C in the general population of Benue State, Central Nigeria. The American Journal of Tropical Medicine and Hygiene, 102(5), 995–1000. https://doi.org/10.4269/ajtmh.19-0649
Maponga, T. G., Glashoff, R. H., Vermeulen, H., Robertson, B., Burmeister, S., Bernon, M., et al. (2020). Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV. BMC Gastroenterology, 20(1), 226. https://doi.org/10.1186/s12876-020-01372-2
Mirambo, M. M., Mbena, P. B., Mushi, M. F., Mtebe, M., Moremi, N., Seni, J., et al. Mshana, S. E. (2015). Prevalence of Hepatitis B surface antigen among pregnant women attending antenatal clinic at Nyamagana District Hospital Mwanza, Tanzania. Tanzania Journal of Health Research, 18(1), 1–3. https://doi.org/10.4314/thrb.v18i1.10
Modi, A. A. and Feld, J. J. (2007). Viral hepatitis and HIV in Africa. AIDS reviews, 9(1), 25–39.
Murewanhema, G., Musuka, G., Moyo, P., Moyo, E. and Dzinamarira, T. (2022). HIV and adolescent girls and young women in sub-Saharan Africa: a call for expedited action to reduce new infections. IJID Regions, 5: 30–32. https://doi.org/10.1016/j.ijregi.2022.08.009
Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) (2019). National Agency for the Control of AIDS (NACA) and Joint United Nations Programme on AIDS-UNAIDS.
Ndifontiayong, A. N., Ali, I. M., Sokoudjou J. B., Ndimumeh J. M. and Tume C. B. (2021). The effect of HBV/HCV in response to HAART in HIV patients after 12 months in Kumba Health District in the South West Region of Cameroon. Tropical Medicine and Infectious Disease, 6, 150. https://doi.org/10.3390/tropicalmed6030150
Okwori, A. E. J., Alabi, S. S., Ngwai, Y. B., Makut, M. D., Obiekezie, S. O., Ishaleku, D., et al. (2013). The seroprevalence of Hepatitis B and C Virus co-infection among HIV-1-infected patients in Keffi, North Central Nigeria. IOSR Journal of Dental and Medical Sciences, 9(5), 70–75. https://doi.org/10.9790/0853-0957075
Omatola, C. A., Idofe, J., Okolo, M. L. O., Adejo, P. O., Maina, M. M. and Oyiguh, J. A. (2019). Seroprevalence of HBV among people living with HIV in Anyigba, Kogi State, Nigeria. African Health Sciences, 19(2), 1938–1946. https://doi.org/10.4314/ahs.v19i2.17
Payne, D., Wadonda-Kabondo, N., Wang, A., Smith-Sreen, J., Kabaghe, A., Bello, G., et al. (2023). Trends in HIV prevalence, incidence, and progress towards the UNAIDS 95-95-95 targets in Malawi among individuals aged 15-64 years: population-based HIV impact assessments, 2015-16 and 2020-21. Lancet HIV, 10(9), e597–e605. https://doi.org/10.1016/S2352-3018(23)00144-3
Petty, L. A., Steinbeck, J. L., Pursell, K. and Jensen, D. M. (2014). Human immunodeficiency virus and coinfection with hepatitis B and C. Infectious Disease Clinics, 28(3), 477–499. https://doi.org/10.1016/j.idc.2014.05.005
Pinchoff, J., Tran, O. C., Chen, L., Bornschlegel, K., Drobnik, A., Kersanske, L., et al. (2016). Impact of hepatitis B on mortality and specific causes of death in adults with and without HIV co-infection in NYC, 2000-2011. Epidemiology and Infection, 144(16), 3354–3364. https://doi.org/10.1017/S0950268816001801
Platt, L., French, C. E., McGowan, C. R., Sabin, K., Gower, E., Trickey, A. et al. (2020). Prevalence and burden of HBV co-infection among people living with HIV: A global systematic review and meta-analysis. Journal of Viral Hepatitis, 27(3), 294–315. https://doi.org/10.1111/jvh.13217
Porras-Ramírez, A. and Rico-Mendoza A. (2020). Coinfection of hepatitis B and C in HIV patients: a review of the state of the art in Hepatitis B and C, ed. Rodrigo L. London: IntechOpen. http://dx.doi.org/10.5772/intechopen.83704
Rajbhandari, R., Jun, T., Khalili, H., Chung, R. T. and Ananthakrishnan, A. N. (2016). HBV/HIV coinfection is associated with poorer outcomes in hospitalized patients with HBV or HIV. Journal of Viral Hepatitis, 23(10), 820–829. https://doi.org/10.1111/jvh.12555
Rodriguez-Garcia, M., Connors, K. and Ghosh, M. (2021). HIV pathogenesis in the human female reproductive tract. Current HIV/AIDS Reports, 18(2), 139–156. https://doi.org/10.1007/s11904-021-00546-1
Seremba, E., Ssempijja, V., Kalibbala, S., Gray, R. H., Wawer, M. J., Nalugod, F., et al. (2017). Hepatitis B incidence and prevention with antiretroviral therapy among HIV-positive individuals in Uganda. AIDS, 31(6), 781–786. https://doi.org/10.1097/qad.0000000000001399
Shahriar, S., Araf, Y., Ahmad, R., Kattel, P., Sah, G. S., Rahaman, T. I. et al. (2022). Insights into the coinfections of human immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: prevalence, risk factors, pathogenesis, diagnosis, and treatment. Frontiers in Microbiology, 12, 780887. https://doi.org/10.3389/fmicb.2021.780887
Van Gerwen, O. T., Muzny, C. A. and Marrazzo, J. M. (2022). Sexually transmitted infections and female reproductive health. Nature Microbiology, 7(8), 1116–1126. https://doi.org/10.1038/s41564-022-01177-x
Vandormael, A., Akullian, A., Siedner, M., De Oliveira, T., Bärnighausen, T. and Tanser, F. (2019). Declines in HIV incidence among men and women in a South African population-based cohort. Nature Communications, 10, 5482. https://doi.org/10.1038/s41467-019-13473-y
WHO, (2017). Global hepatitis report 2017. Geneva: World Health Organization.
Xie, J., Han, Y., Qiu, Z., Li, Y., Li, Y., Song, X., et al. (2016). Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional study. Journal of the International AIDS Society, 19(1), 20659. https://doi.org/10.7448/ias.19.1.20659
Zaw, S. K., Tun, S. T., Thida, A., Aung, T. K., Maung, W., Shwe, M., et al. (2013). Prevalence of hepatitis C and B virus among patients infected with HIV: a cross-sectional analysis of a large HIV care programme in Myanmar. Tropical Doctor, 43(3), 113–115. https://doi.org/10.1177/0049475513493416
Téléchargements
Publiée
Numéro
Rubrique
Comment citer
